All Posts:ALS
-
Georgetown Co-Leads New NIH-Funded Multi-Institutional ALS Clinical Research Consortium
In an effort to disrupt the ALS clinical research landscape in the U.S., the National Institutes of Health has announced the establishment of a transformative national clinical research consortium to be co-led by researchers at Georgetown and three other institutions.
Category: News Release
-
Cancer Drug Prevents Build-up of Toxic Brain Protein
WASHINGTON (May 10, 2013) — Researchers at Georgetown University Medical Center have used tiny doses of a leukemia drug to halt accumulation of toxic proteins linked to Parkinson’s disease in the brains of mice. This finding provides the basis to plan a clinical trial in humans to study the effects. They say their study, published […]
Category: News Release
-
Removing Protein “Garbage” in Nerve Cells May Help Control Two Neurodegenerative Diseases
Neuroscientists at Georgetown University Medical Center say they have new evidence that challenges scientific dogma involving two fatal neurodegenerative diseases — amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD) — and, in the process, have uncovered a possible therapeutic target as a novel strategy to treat both disorders.
Category: News Release